Table 2 Side-to-side differences for each test
Variables | Post-ACLR athletes (n = 21) | P value | Effect size(d) | Healthy athletes (n = 17) | P value | Effect size (d) | ||
|---|---|---|---|---|---|---|---|---|
Involved limb mean ± SD (range) | Uninvolved limb mean ± SD (range) | Poor-performing limb mean ± SD (range) | Well-performing limb mean ± SD (range) | |||||
SHD (cm) | 135.1 ± 26.8 (99.5–191.5) | 142.1 ± 26.2 (97.5–195.0) | 0.006 | 0.26 | 136.6 ± 24.2 (101.0–188.5) | 143.5 ± 26.6 (103–197.5) | < 0.001 | 0.27 |
THD (cm) | 407.2 ± 69.6 (286.5–557.5) | 429.1 ± 72.3 (315.0–633.0) | 0.001 | 0.31 | 450.7 ± 67.3 (365.0–607.0) | 471.0 ± 68.6 (389.5–614.5) | < 0.001 | 0.30 |
CHD (cm) | 354.5 ± 64.3 (257.5–493.0) | 379.1 ± 73.7 (261.0–517.5) |  < 0.001 | 0.36 | 401.5 ± 68.7 (293.5–555.0) | 419.1 ± 71.9 (304.0–556.5) | < 0.001 | 0.25 |
CT during SVCJs (sec) | 0.26 ± 0.03 (0.21–0.33) | 0.25 ± 0.03 (0.21–0.30) |  < 0.001 | 0.33 | 0.24 ± 0.02 (0.19–0.27) | 0.23 ± 0.02 (0.19–0.26) | < 0.001 | 0.50 |
JH during SVCJs (cm) | 10.1 ± 2.4 (6.9–17.7) | 11.9 ± 3.1 (7.8–20.7) |  < 0.001 | 0.65 | 12.5 ± 3.4 (7.6–22.2) | 13.6 ± 3.4 (8.6–22.4) | < 0.001 | 0.32 |
RSI during SVCJs (cm/s) | 38.8 ± 9.5 (25.4–65.0) | 48.4 ± 11.4 (26.6–73.0) |  < 0.001 | 0.92 | 52.3 ± 13.7 (27.9–88.2) | 57.7 ± 14.0 (33.4–90.5) |  < 0.001 | 0.39 |